Substantiation of technology and standardization of extraction preparations based on Melissa officinalis herb
- Authors: Epifanova A.I.1, Kurkin V.A.1, Kurkina A.V.1, Mubinov A.R.1, Braslavsky V.B.1
-
Affiliations:
- Samara State Medical University
- Issue: Vol 74, No 3 (2025)
- Pages: 36-42
- Section: Technology of medicines
- URL: https://journals.eco-vector.com/0367-3014/article/view/680114
- DOI: https://doi.org/10.29296/25419218-2025-03-05
- ID: 680114
Cite item
Abstract
Introduction. Melissa officinalis L. is one of the most popular plants due to its rich composition of biologically active compounds. The uniqueness of Melissa officinalis lies in the combination of anxiolytic, sedative, antiviral and antihistamine properties. Currently, the problem of creating import-substituting medicines is very urgent, which should be accompanied by standardization of quantitative analysis methods. In this regard, high-performance liquid chromatography is a promising method. In accordance with the Russian Federation State Budget of the XIV edition, the standardization of Melissa officinalis herb is carried out by spectrophotometry of the content of phenolic compounds (phenylpropanoids) calculated on rosmarinic acid.
The aim. Study to substantiate the technology and methods of standardization of extraction preparations based on the herb of Melissa officinalis.
Material and methods. Melissa officinalis herb cultivated near the village of Alekseevka, Samara region, was used as an object of research (harvest time – July 2024). Tinctures were obtained by modified maceration from Melissa officinalis herb based on an extractant – ethyl alcohol at concentrations of 40% and 70%, from which thick extracts were further developed. These extraction preparations, as well as the resulting infusion (1:10), were analyzed by spectrophotometry and high-performance liquid chromatography.
Results. Using the spectrophotometry method, it was determined that the content of the total phenylpropanoids (calculated on rosmarinic acid) in samples of tincture on 40% ethyl alcohol, tincture on 70% ethyl alcohol; thick extract on 40% ethyl alcohol, thick extract on 70% ethyl alcohol and infusion is 0,83 ± 0,02; 0,65 ± 0,01; 9,07 ± 0,45; 5,58 ± 0,26 and 0,22 ± 0,01% accordingly.
As a result of the conducted research, a method has been developed for the quantitative determination of rosmarinic acid in extraction preparations based on Melissa officinalis herb using the HPLC method. It was determined that the content of rosmarinic acid in the samples of tincture on 40% ethyl alcohol, tincture on 70% ethyl alcohol; thick extract on 40% ethyl alcohol, thick extract on 70% ethyl alcohol and infusion is 0,46 ± 0,01; 0,33 ± 0,01; 4,10 ± 0,20; 5,11 ± 0,25 and 0,14 ± 0,01% accordingly.
Conclusion. A study using spectrophotometry and HPLC revealed shown that 40% ethyl alcohol is the optimof al extractant for extracting the amount of phenylpropanoids and rosmarinic acid from the herb Melissa officinalis. The expediency of standardization of extraction preparations based on Melissa officinalis herbs on content of rosmarinic acid using HPLC method was substantiated.
Full Text

About the authors
Alina Irecovna Epifanova
Samara State Medical University
Email: epifanova.a01@mail.ru
ORCID iD: 0009-0004-4481-6981
Postgraduate Student of the Department of Pharmaceutical Technology with a Course in Biotechnology
Russian Federation, SamaraVladimir Aleksandrovich Kurkin
Samara State Medical University
Email: v.a.kurkin@samsmu.ru
ORCID iD: 0000-0002-7513-9352
Doctor of Pharmaceutical Sciences, Professor, Head of the Department of Pharmacognosy with Botany and the Basics of Phytotherapy
Russian Federation, SamaraAnna Vladimirovna Kurkina
Samara State Medical University
Email: a.v.kurkina@samsmu.ru
ORCID iD: 0000-0002-5028-9186
Doctor of Pharmaceutical Sciences, Professor, Head of the Department of Pharmaceutical Technology with a Course in Biotechnology
Russian Federation, SamaraArtur Rustemovich Mubinov
Samara State Medical University
Email: a.r.mubinov@samsmu.ru
ORCID iD: 0000-0002-4791-4606
Candidate of Pharmaceutical Sciences, Leading Researcher at the Pharmacy Scientific and Educational Center
Russian Federation, SamaraValery Borisovich Braslavsky
Samara State Medical University
Author for correspondence.
Email: v.b.braslavskii@samsmu.ru
ORCID iD: 0000-0002-6050-3377
Doctor of Pharmaceutical Sciences, Associate Professor at the Department of Pharmacognosy with Botany and the Basics of Phytotherapy
Russian Federation, SamaraReferences
- Куркин В.А., Мазур А.В., Алексеева А.В. Мелисса лекарственная: перспективы использования в педиатрии. Монография. 2010; 164. [Kurkin V.A., Mazur A.V., Alekseeva A.V. Medicinal melissa: prospects for use in pediatrics. The monograph. 2010; 164 (in Russian)].
- Справочник Видаль «Лекарственные препараты в России» [Электронное издание]. Режим доступа: https://www.vidal.ru Vidal's Handbook of Medicines in Russia [Electronic resource]. Access mode: https://www.vidal.ru (in Russian).
- Куркин В.А. Фармакогнозия: учебник для студентов фармацевтических вузов (факультетов), 6-е изд. перераб. и доп. 2024. 1268. [Kurkin V.A., Pharmacognosy: a textbook for students of pharmaceutical universities (faculties), 6th ed. reprint. and add. 2024. 13268 (in Russian)].
- Государственная фармакопея РФ XIV изд. [Электронное издание]. Режим доступа:http://femb.ru/feml The State Pharmacopoeia оf the Russian Federation, XIV-ed. [Electronic resource]. Access mode: http://femb.ru/feml (in Russian).
- Епифанова А.И., Куркина А.В., Климова Л.Д., Куркин В.А., Егорова А.В., Мубинов А.Р. Технологическое обоснование создания противотревожных препаратов на основе травы мелиссы лекарственной. Современные проблемы фармации: материалы Научно-практической онлайн-конференции. Сборник. 2024; 102–5. [Epifanova A.I., Kurkina A.V., Klimova L.D., Kurkin V.A., Egorova A.V., Mubinov A.R. Technological justification for the creation of anti-anxiety drugs based on Melissa officinalis herb. Modern problems of pharmacy: materials of the Scientific and practical online conference. Collection. 2024; 102–5 (in Russian)].
- Dastmalchi K., Ollilainen V., Lackman P., Boije af Gennas G., Dorman H.J., Jarvinen P.P., et al. Acetylcholinesterase inhibitory guided fractionation of Melissa officinalis L. Bioorg. Med. Chem. 2008; 17 (2): 867–71. doi: 10.1016/j.bmc.2008.11.034.
- Liao D., Liu Y., Ouyang Z., Feng P., Li C. Effects of Melissa officinalis (Lemon Balm) on cardio-metabolic outcomes: A systematic review and meta-analysis. Phytother Res. 2020; 34 (12): 3113–23. doi: 10.12691/jfnr-9-7-5.
- Safari M., Asadi A., Aryaeian N., Huseini H., Shidfar F., Jazayeri S., Malek M., Hosseini A., Hamidi Z. The effects of Melissa officinalis on depression and anxiety in type 2 diabetes patients with depression: a randomized double-blinded placebo-controlled clinical trial. BMC Complement Med Ther. 2023; 23 (1): 140. doi: 10.1186/s12906-023-03978-x.
- Watson K., Hatcher D., Good A. A randomised controlled trial of Lavender (Lavandula angustifolia) and Lemon Balm (Melissa officinalis) essential oils for the treatment of agitated behaviour in older people with and without dementia. Complement Ther. Med. 2019; 42: 366–73. doi: 10.1016/j.ctim.2018.12.016.
- Ghazizadeh J., Sadigh-Eteghad S., Marx W., Fakhari A., Hamedeyazdan S., Torbati M., Taheri-Tarighi S., Araj-Khodaei M., Mirghafourvand M. The effects of lemon balm (Melissa officinalis L.) on depression and anxiety in clinical trials: A systematic review and meta-analysis. Phytother Res. 2021; 35 (12): 6690–705. doi: 10.1002/ptr.7252.
- European Pharmacopoeia, 11th-edition [Electronic resource]. Access mode: http:// edqm.eu/en/european-pharmacopoeia-ph.-eur.-11th-edition.
Supplementary files
